{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:10:32Z","timestamp":1754395832961,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s12185-018-2423-5","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T08:15:22Z","timestamp":1520237722000},"page":"76-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3242-6917","authenticated-orcid":false,"given":"Hideki","family":"Sano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Waragai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ohto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kikuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"2423_CR1","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"CH Pui","year":"2015","unstructured":"Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015;33:2938\u201348.","journal-title":"J Clin Oncol"},{"key":"2423_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/bjh.12040","volume":"159","author":"JE Rubnitz","year":"2012","unstructured":"Rubnitz JE, Inaba H. Childhood acute myeloid leukaemia. Br J Haematol. 2012;159:259\u201376.","journal-title":"Br J Haematol"},{"key":"2423_CR3","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1200\/JCO.2009.25.1983","volume":"28","author":"G Tallen","year":"2010","unstructured":"Tallen G, Ratei R, Mann G, Kaspers G, Niggli F, Karachunsky A, et al. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. J Clin Oncol. 2010;28:2339\u201347.","journal-title":"J Clin Oncol"},{"key":"2423_CR4","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/S0140-6736(10)62002-8","volume":"376","author":"C Parker","year":"2010","unstructured":"Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV, et al. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet. 2010;376:2009\u201317.","journal-title":"Lancet"},{"key":"2423_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12185-014-1616-9","volume":"100","author":"H Nakayama","year":"2014","unstructured":"Nakayama H, Tabuchi K, Tawa A, Tsukimoto I, Tsuchida M, Morimoto A, et al. Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol. Int J Hematol. 2014;100:171\u20139.","journal-title":"Int J Hematol"},{"key":"2423_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1365-2141.2005.05773.x","volume":"131","author":"PS Gaynon","year":"2005","unstructured":"Gaynon PS. Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol. 2005;131:579\u201387.","journal-title":"Br J Haematol"},{"key":"2423_CR7","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","volume":"28","author":"M Duval","year":"2010","unstructured":"Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010;28:3730\u20138.","journal-title":"J Clin Oncol"},{"key":"2423_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(05)66998-X","volume":"366","author":"A Balduzzi","year":"2005","unstructured":"Balduzzi A, Valsecchi MG, Uderzo C, De Lorenzo P, Klingebiel T, Peters C, et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet. 2005;366:635\u201342.","journal-title":"Lancet"},{"key":"2423_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/tme.12150","volume":"24","author":"S Kobayashi","year":"2014","unstructured":"Kobayashi S, Ito M, Sano H, Mochizuki K, Akaihata M, Waragai T, et al. T-cell-replete haploidentical stem cell transplantation is highly efficacious for relapsed and refractory childhood acute leukaemia. Transfus Med. 2014;24:305\u201310.","journal-title":"Transfus Med"},{"key":"2423_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJM199403243301206","volume":"330","author":"JO Armitage","year":"1994","unstructured":"Armitage JO. Bone marrow transplantation. N Engl J Med. 1994;330:827\u201338.","journal-title":"N Engl J Med"},{"key":"2423_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0198-8859(90)90071-V","volume":"29","author":"C Anasetti","year":"1990","unstructured":"Anasetti C, Beatty PG, Storb R, Martin PJ, Mori M, Sanders JE, et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol. 1990;29:79\u201391.","journal-title":"Hum Immunol"},{"key":"2423_CR12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555\u201362.","journal-title":"Blood"},{"key":"2423_CR13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","volume":"15","author":"R Szydlo","year":"1997","unstructured":"Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15:1767\u201377.","journal-title":"J Clin Oncol"},{"key":"2423_CR14","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","volume":"23","author":"F Aversa","year":"2005","unstructured":"Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005;23:3447\u201354.","journal-title":"J Clin Oncol"},{"key":"2423_CR15","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","volume":"107","author":"DP Lu","year":"2006","unstructured":"Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 2006;107:3065\u201373.","journal-title":"Blood"},{"key":"2423_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1200\/JCO.2006.07.0953","volume":"25","author":"DA Rizzieri","year":"2007","unstructured":"Rizzieri DA, Koh LP, Long GD, Gasparetto C, Sullivan KM, Horwitz M, et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol. 2007;25:690\u20137.","journal-title":"J Clin Oncol"},{"key":"2423_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","volume":"8","author":"PV O\u2019Donnell","year":"2002","unstructured":"O\u2019Donnell PV, Luznik L, Jones RJ, Vogelsang GB, Leffell MS, Phelps M, et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2002;8:377\u201386.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2423_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.bbmt.2015.04.012","volume":"21","author":"K Ikegame","year":"2015","unstructured":"Ikegame K, Yoshida T, Yoshihara S, Daimon T, Shimizu H, Maeda Y, et al. Unmanipulated haploidentical reduced-intensity stem cell transplantation using fludarabine, busulfan, low-dose antithymocyte globulin, and steroids for patients in non-complete remission or at high risk of relapse: a prospective multicenter phase I\/II study in Japan. Biol Blood Marrow Transplant. 2015;21:1495\u2013505.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2423_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1399-0012.2010.01352.x","volume":"25","author":"K Mochizuki","year":"2011","unstructured":"Mochizuki K, Kikuta A, Ito M, Sano H, Akaihata M, Kobayashi S, et al. Feasibility of tacrolimus, methotrexate, and prednisolone as a graft-versus-host disease prophylaxis in non-T-cell-depleted haploidentical hematopoietic stem cell transplantation for children. Clin Transplant. 2011;25:892\u20137.","journal-title":"Clin Transplant"},{"key":"2423_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"2423_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141\u201354.","journal-title":"Ann Stat"},{"key":"2423_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2423_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1056\/NEJM198901263200401","volume":"320","author":"C Anasetti","year":"1989","unstructured":"Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner D, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989;320:197\u2013204.","journal-title":"N Engl J Med"},{"key":"2423_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bbmt.2010.08.023","volume":"17","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu DH, Xu LP, Liu KY, Chen H, Chen YH, et al. Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison. Biol Blood Marrow Transpl. 2011;17:821\u201330.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2423_CR25","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V91.7.2360","volume":"91","author":"L Genestier","year":"1998","unstructured":"Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, Bonnefoy-Berard N. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood. 1998;91:2360\u20138.","journal-title":"Blood"},{"key":"2423_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12967-015-0748-x","volume":"13","author":"J Liu","year":"2015","unstructured":"Liu J, Xu LP, Bian Z, Chang YJ, Wang Y, Zhang XH, et al. Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation. J Transl Med. 2015;13:391. https:\/\/doi.org\/10.1186\/s12967-015-0748-x .","journal-title":"J Transl Med"},{"key":"2423_CR27","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.bbmt.2012.06.014","volume":"18","author":"D Weisdorf","year":"2012","unstructured":"Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M. Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Biol Blood Marrow Transpl. 2012;18:1727\u201333.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2423_CR28","doi-asserted-by":"publisher","unstructured":"O\u2019Hare P, Lucchini G, Cummins M, Veys P, Potter M, Lawson S, et al. Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience. Bone Marrow Transpl. 2017. https:\/\/doi.org\/10.1038\/bmt.2017.3 (e-pub ahead of print 20 February 2017).","DOI":"10.1038\/bmt.2017.3"},{"key":"2423_CR29","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/bmt.2013.99","volume":"48","author":"DH Liu","year":"2013","unstructured":"Liu DH, Xu LP, Liu KY, Wang Y, Chen H, Han W, et al. Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia. Bone Marrow Transpl. 2013;48:1519\u201324.","journal-title":"Bone Marrow Transpl"},{"key":"2423_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3109\/08880018.2014.961214","volume":"31","author":"A Sawada","year":"2014","unstructured":"Sawada A, Shimizu M, Isaka K, Higuchi K, Mayumi A, Yoshimoto Y, et al. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies. Pediatr Hematol Oncol. 2014;31:754\u201364.","journal-title":"Pediatr Hematol Oncol"},{"key":"2423_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/petr.12724","volume":"20","author":"SR Jaiswal","year":"2016","unstructured":"Jaiswal SR, Chakrabarti A, Chatterjee S, Ray K, Chakrabarti S. Haploidentical transplantation in children with unmanipulated peripheral blood stem cell graft: the need to look beyond post-transplantation cyclophosphamide in younger children. Pediatr Transplant. 2016;20:675\u201382.","journal-title":"Pediatr Transplant"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2423-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T23:41:29Z","timestamp":1603928489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2423-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["2423"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2423-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"6 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}